Genetix Biotherapeutics and the National Football League Alumni Association Announce Partnership to Increase Awareness for Sickle Cell Disease and Transformative Treatment Options
SK Capital
Jon Borell Appointed as Member of SK Capital Executive Committee
Milestone
SK Capital Reaches Agreement to Sell Milestone Environmental to I Squared Capital
Apotex
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Genetix
Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region
Apotex
Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full